IL10 and diabetes mellitus: Because tDCs are often seen to release IL-10, TGF-β, and retinoic acid [158,159], stable Tregs will, in turn, affect the tDC tolerance status through intercellular interactions and paracrine immunomodulatory cytokines, which may result in much more effective and long-term protection from diabetes.